filmov
tv
Clinical usage of antibody: Herceptin (Antibody as breast cancer medicine)
Показать описание
This video describes how Herceptin which is a monoclonal antibody works and could be used for the treatment of Her2+ve breast cancer.
0:08:13
Clinical usage of antibody: Herceptin (Antibody as breast cancer medicine)
0:03:20
How Monoclonal Antibodies Treat Cancer
0:05:44
Herceptin—a targeted antibody therapy for breast cancer
0:51:06
Biosimilars and Oncology Clinical Pathways: Perfect Together
0:03:32
Monoclonal Antibodies and its Production
0:51:40
TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal
0:44:23
Metastatic Breast Cancer: Leveraging Clinical Pathways to Navigate a Complex Treatment Landscape:
0:04:31
Study of Atezolizumab with Pertuzumab and Trastuzumab in HER2- Positive Metastatic Breast Cancer
0:47:29
Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani
0:03:50
Herceptin (trastuzumab) for HER2-Positive Breast and Stomach Cancer
0:08:31
Trastuzumab (Herceptin) and Pertuzumab (Perjeta) for Breast Cancer: What You Need to Know
0:01:56
PERSEPHONE: 6 vs. 12-month adjuvant trastuzumab in early breast cancer
0:01:52
How Do Drugs Work: monoclonal Antibody: Anti-Neoplastic Drug -- Trastuzumab (Herceptin®)
0:04:27
Study of Immunotherapy Combinations for Patients with HER2-Positive Metastatic Breast Cancer
0:01:31
Current Treatment Options for Patients With HER2-Positive Metastatic Breast Cancer
0:02:06
Trastuzumab Deruxtecan for Breast Cancer | NEJM
0:53:19
HER2 Positive Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019
0:08:42
Antibody therapy
0:00:56
How do monoclonal antibodies kill cancer cells? | Breast Cancer Treatment | Dr Jay Anam
0:10:40
INB03 and Lapatinib Reverses Resistance to Trastuzumab in HER2+ Breat Cancer in Pre-clinical Models.
0:23:52
Breast Cancer and the Immune System at MBC Patient Forum 2019
1:11:23
HER2 Positive Breast Cancer Management
0:52:21
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Irene and Dr. Vogel
1:01:35
HER2+ Treatment
Комментарии